Neutralizing antibodies during treatment of secondary progressive MS with interferon β-1b
Chris H. Polman(Vrije Universiteit Amsterdam), D. Miller(National Hospital), F. Dahlke(National Hospital), K. Beckmann(Ophthalmology Clinic), Alan J. Thompson(Queen Mary University of London), John Petkau(National Multiple Sclerosis Society), Carlo Pozzilli(Ophthalmology Clinic), Ludwig Kappos(University Hospital of Basel), Rick White(University of British Columbia)
Cited by 107
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
|Annals of Neurology|2001|7k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k